“I hope that we can address all of them,” he said. “And I hope that will be bipartisan.”

The Inflation Reduction Act, which passed the Senate on a party-line vote, included a number of drug pricing provisions, among them capping out-of-pocket spending for Medicare Part D enrollees and requiring the federal government to negotiate prices for some drugs covered under Medicare. The measure limits the monthly cost of insulin to $35, but only for those who are covered by Medicare. It also further delayed implementation of a drug rebate rule issued by the Trump administration that would have similarly banned the rebates Hawley is targeting, but only for Medicare.เว็บคาสิโนออนไลน์อันดับ1